Neuropeptide Substance-P Modulates Electrical Characteristics of Rabbit Atrial Myocytes  by Geuzebroek, Guillaume S.C. et al.
282a Monday, February 4, 2013sex difference of QT intervals and risks of arrhythmia. We here seek the under-
lying mechanisms on the regulation of ICa,L in patch-clamped guinea pig ven-
tricular myocytes. An external application of P4 (100 nM) suppressed ICa,L
about 30 % (100 nM P4; 5854 %, n=13, without P4 (time control); 8452 %,
n=5). In the presence of a specific PDE2 inhibitor, EHNA (30 mM), P4 sup-
pressed ICa,L to 8455 % (n=7), which is the same extent with the time control.
Pharmacological studies revealed that hydrolysis of cAMP by a cGMP-
stimulated phosphodiesterase (PDE2) involves in the P4-induced ICa,L suppres-
sion. However the underlying mechanisms of the ICa,L suppression remain to be
solved. Thus, we employed sucrose density gradient fractionation experiments
to examine localization of the molecules in this system, which is dependent of
lipid-raft composition. We found that substantial fraction of CaV1.2 and PDE2
clustered in caveolae fractions, but PDE3 clustered in extra-caveolae fractions.
Furthermore, a proximity ligation assay (Olink) revealed that CaV1.2 interacted
both with PDE2 and PDE3, but there was no interaction between PDE2 and
PDE3. These results suggest that PDE2 and the L-type Ca2þ channel co-
localizes at the caveolae for the non-genomic regulation of ICa,L by P4.
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Background: The cardiac nervous system plays an important role in the initi-
ation and maintenance of atrial fibrillation (AF). Besides the classical neuro-
transmitters, the nerves innervating the atria also release a wide range of
neuropeptides that may play a role in the pathophysiology of AF. Since the di-
rect effect of these neuropeptides on atrial myocytes is largely unknown, we
investigated the electrophysiological response of atrial myocytes to several
neuropeptides, importantly substance-P (Sub-P).
Methods and Results: Single left atrial myocytes from rabbit hearts were ob-
tained by enzymatic dissociation and the effects of Sub-P, neuropeptide-Y
(NPY), somatostatin-14 (SOM-14) and vasoactive intestinal peptide (VIP),
were studied using patch-clamp and indo-1 fluorescence methodologies.
NPY, SOM-14 and VIP (1 mM) did not affect atrial action potential (AP)
characteristics. Sub-P however, reduced both resting membrane potential
(RMP) and action potential amplitude, and increased action potential dura-
tion at 90% of repolarisation (APD90) by 40%. The effects on APD90 were
dose-dependent and occurred from a concentration of 10 nM. Voltage-
clamp analysis revealed that Sub-P significantly diminished L-type calcium
current, inward rectifier Kþ current (IK1) and an unknown steady-state out-
ward current. Transient outward current, Ca2þ- activated chloride current
and Naþ-Ca2þ-exchanger current were unaffected, as was the intracellular
calcium handling. The reduction in RMP and increase in APD90 are likely
due to the decrease in IK1 and steady-state outward current, respectively.
Our experiments indicate that the latter is probably carried by background-
like potassium channels.
Conclusion: Atrial myocyte electrophysiology is significantly modulated by
the neuropeptide Sub-P, mainly characterized by a substantial AP prolongation
due to inhibition of a background potassium current. Since lengthening of atrial
repolarization is potentially anti-arrhythmic, we hypothesize that release of
Sub-P may be beneficial to the prevention and/or termination of AF.
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Inherited dilated cardiomyopathy (DCM), characterized by dilation and im-
paired systolic function of ventricle, is a progressive disease often resulting
in death with congestive heart failure (CHF) or sudden death (SD). It remains
unclear how electrical remodeling proceed in inherited DCM. Furthermore, al-
though angiotensin II receptor blockers (ARBs) is known to have beneficial ef-
fects on HF in general, little is known about the effects of ARB on the electrical
remodeling in inherited DCM. The aim of our study was to investigate effects
of ARB on the remodeling in inherited DCM hearts using a knock-in mouse
model of DCM (TNNT2 DK210). In DCM mice at 2 months of age when mor-
tality rate abruptly increased, myocardium showed a significant reduction in
Kþ current density with substantial decreases in expression of Kv4.2, Kv1.5and KChIP2. In contrast, at 1 month, down-regulation of Kv1.5 or KChIP2
was not observed, but up-regulation of Cav3.1 was detected. At 3 months,
some of DCM mice showed a lung edema, a sign of CHF. CHF myocardium
showed further decrease in expression of the various Kþ channels. Treatment
with ARB, candesartan, started at 1 months, considerably extended lifespan of
DCM mice. Interestingly, expression changes that occurred in later phase were
inhibited by ARB whereas changes occurred at early stage were not affected.
Our results indicate that the electrical remodeling at later stage of DCM is
critical for survival of this mouse model and the remodeling is controllable
by ARB.
1450-Pos Board B342
The Role of CGMP Dependent Nitric Oxide Signalling on Cardiac
Repolarisation in Adult Guinea Pig Ventricular Myocytes
Rachel E. Caves, Kieran Brack, Andre Ng, John Mitcheson.
University of Leicester, Leicester, United Kingdom.
Recently, roles for nitric oxide (NO) signalling pathways have been linked
with abnormalities in cardiac repolarisation and cardiac arrhythmias. Studies
from isolated heart preparations have demonstrated an antifibrillatory effect
following vagus nerve stimulation, which is NO dependent. The cellular
and molecular basis for this protective effect is unknown. In this study,
cGMP dependent regulation of repolarisation was investigated using BAY
60-2770, a novel NO and haem independent soluble guanylyl cyclase
(sGC) activator. Action potentials and currents were recorded from isolated
guinea pig ventricular myocytes using the perforated patch clamp technique.
Cellular cGMP was quantified by radioimmunoassay and expressed as a fold
change relative to basal levels. 1 mM BAY 60-2770 increased cellular cGMP
by 2.2 fold and by 7.1 fold in the presence of 100 mM IBMX (3-Isobutyl-1-
methylxanthine), a non-selective phosphodiesterase (PDE) inhibitor. In vitro
assays on purified sGC have shown that ODQ (1H-[1,2,4]Oxadiazolo[4,3-a]
quinoxalin-1-one) potentiates the action of BAY 60-2770. This was corrobo-
rated in our experiments, BAY 60-2770 þ 10 mM ODQ increased cGMP by
27.9 fold. Despite substantial increases in cellular cGMP, changes in times to
90% repolarisation (APD90) were modest. BAY 60-2770 shortened APD90 by
11.3 ms and adding ODQ to BAY 60-2770 caused no further APD90 shorten-
ing. In contrast, when cGMP hydrolysis was blocked by IBMX, BAY
60-2770 lengthened APD90 by 15.7 ms. Preliminary findings indicate that de-
layed rectifier potassium currents are modulated by these pathways. Overall,
these findings demonstrate the complex interplay between cGMP and cAMP
mediated effects on the ion channels regulating cardiac repolarisation. The
modest effect of BAY 60-2770 þ ODQ on APD90, despite a substantial in-
crease in cellular cGMP, highlights that PDEs limit cGMP accumulation
close to ion channels in the sarcolemma, thus compartmentalising cGMP
signalling.
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The universal second messenger 3’,5’-cyclic adenosine monophosphate
(cAMP) has been considered for many years the main regulator of several cel-
lular physiopathological process uniquely via protein kinase A (PKA) activa-
tion. However, in the last years the discovery of a new sensor for cAMP
named Epac (exchange protein directly activated by cAMP) has profoundly
changed this cAMP-PKA dogma. We have recently shown that Epac activa-
tion activates excitation-transcription coupling and, as a result, in few hours
has a positive inotropic effect, which differs from acute effects. These data
suggests that Epac modulates the expression of different proteins involved
in excitation-contraction coupling. We analyzed the possible modulator effect
of Epac on ionic currents in rat cardiac myocytes incubated or not in the pres-
ence of the selective Epac activator, 8-pCPT. We analyzed L-type Ca2þ cur-
rent (ICa) and background currents by patch-clamp in the whole cell
configuration. We found that while the peak of L-type Ca2þ current was
not significantly altered by Epac activation, there was a shift in the voltage-
dependent activation curve towards more hyperpolarized potentials. However,
the voltage-dependent inactivation curve was not significantly modified by
Epac. As a result, the ICa window current was higher in the Epac-activated
group, which is associated with calmodulin upregulation and could contribute
to the positive-inotropic effect but also induce arrhythmia. The background
current was increased by Epac activation and is currently under investigation.
We conclude that Epac sustained activation induce electrophysiological
changes in the cardiac myocyte.
